Prostaglandin E2 potentiates platelet aggregation by priming protein kinase C

Prostaglandin E2 potentiates platelet aggregation by priming protein kinase C

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	R Vezza, Rita Roberti, GG Nenci, Paolo Gresele
Format:	Artigo
Langue:	anglais
Publié:	1993
Accès en ligne:	https://doi.org/10.1182/blood.v82.9.2704.2704 https://ashpublications.org/blood/article-pdf/82/9/2704/612085/2704.pdf
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Evidence for a storage pool defect in platelets from cirrhotic patients with defective aggregation
par: Giacomo Laffi, et autres
Publié: (1992)

Intraplatelet signaling mechanisms of the priming effect of matrix metalloproteinase-2 on platelet aggregation
par: Emanuela Falcinelli, et autres
Publié: (2005)

Activated human protein C prevents thrombin-induced thromboembolism in mice. Evidence that activated protein c reduces intravascular fibrin accumulation through the inhibition of additional thrombin generation.
par: Paolo Gresele, et autres
Publié: (1998)

Potentiation of aggregation and inhibition of adenylate cyclase in human platelets by prostaglandin E analogues.
par: Matthews, J. S., et autres
Publié: (1993)

Ca2+ mobilization primes protein kinase C in human platelets. Ca2+ and phorbol esters stimulate platelet aggregation and secretion synergistically through protein kinase C.
par: Siess, W, et autres
Publié: (1988)

The mechanism of adenosine diphosphate induced platelet aggregation: binding to platelet receptors and inhibition of binding and aggregation by prostaglandin E(1)
par: Boullin, D. J., et autres
Publié: (1972)

Formation of Prostaglandins during the Aggregation of Human Blood Platelets
par: Smith, J. B., et autres
Publié: (1973)

Formation of Prostaglandins during the Aggregation of Human Blood Platelets
par: J. Bryan Smith, et autres
Publié: (1973)

Prostaglandin E1 and forskolin antagonize C-kinase activation in the human platelet.
par: de Chaffoy de Courcelles, D, et autres
Publié: (1987)

The mechanism of adenosine diphosphate induced platelet aggregation: binding to platelet receptors and inhibition of binding and aggregation by prostaglandin E<sub>1</sub>
par: D J Boullin, et autres
Publié: (1972)

Effects of synthetic prostaglandin analogues on platelet aggregation and secretion [proceedings].
par: Corey, E J, et autres
Publié: (1977)

Isolation and Structure of Two Prostaglandin Endoperoxides That Cause Platelet Aggregation
par: Hamberg, Mats, et autres
Publié: (1974)

Isolation and Structure of Two Prostaglandin Endoperoxides That Cause Platelet Aggregation
par: Mats Hámberg, et autres
Publié: (1974)

Platelet aggregation and exposure of fibrinogen receptors by prostaglandin endoperoxide analogues
par: TA Morinelli, et autres
Publié: (1983)

Altered platelet function associated with the bronchial hyperresponsiveness accompanying nocturnal asthma
par: Paolo Gresele, et autres
Publié: (1993)

Prostaglandin E(2 )acts via the EP(4 )receptor to inhibit platelet aggregation
par: Philipose, Sonia, et autres
Publié: (2009)

Diabetes Mellitus, Hypercholesterolemia, and Hypertension but Not Vascular Disease Per Se Are Associated With Persistent Platelet Activation In Vivo
par: Giovanni Davı̀, et autres
Publié: (1997)

Activated human protein C prevents thrombin-induced thromboembolism in mice. Evidence that activated protein c reduces intravascular fibrin accumulation through the inhibition of additional thrombin generation.
par: Gresele, P, et autres
Publié: (1998)

Effect of ethanol on vascular prostacyclin (prostaglandin I2) synthesis, platelet aggregation, and platelet thromboxane release.
par: Mikhailidis, D P, et autres
Publié: (1983)

Effect of ethanol on vascular prostacyclin (prostaglandin I2) synthesis, platelet aggregation, and platelet thromboxane release.
par: Dimitri P. Mikhailidis, et autres
Publié: (1983)

Inhibition of prostaglandin E1-responsive platelet adenylate cyclase by heparin: a study of the mechanism of inhibition and its relevance to platelet aggregation
par: Amirrasooli, H., et autres
Publié: (1981)

The Prostaglandin E <sub>2</sub> Receptor EP4 Is Expressed by Human Platelets and Potently Inhibits Platelet Aggregation and Thrombus Formation
par: Sonia Philipose, et autres
Publié: (2010)

Thrombopoietin primes human platelet aggregation induced by shear stress and by multiple agonists
par: A. Oda, et autres
Publié: (1996)

Inhibition of platelet aggregation by prostaglandin E1 (PGE1) in diabetic patients during therapy with clopidogrel and aspirin
par: KREUTZ, ROLF P., et autres
Publié: (2012)

Anti-platelet therapy: phosphodiesterase inhibitors
par: Gresele, Paolo, et autres
Publié: (2011)

Anti‐platelet therapy: phosphodiesterase inhibitors
par: Paolo Gresele, et autres
Publié: (2011)

LPS stimulates platelet secretion and potentiates platelet aggregation via TLR4/MyD88 and the cGMP-dependent protein kinase pathway
par: Zhang, Guoying, et autres
Publié: (2009)

Lipopolysaccharide Stimulates Platelet Secretion and Potentiates Platelet Aggregation via TLR4/MyD88 and the cGMP-Dependent Protein Kinase Pathway
par: Guoying Zhang, et autres
Publié: (2009)

Prostaglandin endoperoxides, thromboxane A2 and adenosine diphosphate in collagen-induced aggregation of rabbit platelets
par: Lewis, G. P., et autres
Publié: (1982)

Single-blind study of epoprostenol and 6-keto-prostaglandin E1 in man: effects of platelet aggregation and plasma renin.
par: Miyamori, I, et autres
Publié: (1985)

Platelets and Airway Diseases
par: Momi, Stefania, et autres
Publié: (2017)

The effect of a prostaglandin DP-receptor partial agonist (192C86) on platelet aggregation and the cardiovascular system in healthy volunteers.
par: Gray, S J, et autres
Publié: (1992)

Learning the Ropes of Platelet Count Regulation: Inherited Thrombocytopenias
par: Bury, Loredana, et autres
Publié: (2021)

Proceedings: Effects of prostaglandins E1, E2 and D2 on platelet aggregation: variation with animal species and ionized calcium concentration.
par: Gordon, J L, et autres
Publié: (1975)

Receptor- and phorbol-ester-mediated redistribution of protein kinase C in human platelets. Evidence that aggregation promotes degradation of protein kinase C.
par: Wheeler-Jones, C P, et autres
Publié: (1989)

Antiplatelet Therapy in Low-Platelet-Count Patients After Percutaneous Coronary Intervention for Acute Coronary Syndromes
par: Francesco Paciullo, et autres
Publié: (2025)

Effect of prostaglandin E1 alone and in combination with theophylline or aspirin on collagen-induced platelet aggregation and on platelet nucleotides including adenosine 3′:5′-cyclic monophosphate
par: Ball, G., et autres
Publié: (1970)

Effect of prostaglandin E1 alone and in combination with theophylline or aspirin on collagen-induced platelet aggregation and on platelet nucleotides including adenosine 3′:5′-cyclic monophosphate
par: Ge. Ball, et autres
Publié: (1970)

Creatine kinase inhibits ADP-induced platelet aggregation
par: Horjus, D. L., et autres
Publié: (2014)

The effect of pulmonary metabolites of prostaglandins E1, E2 and F2alpha on ADP-induced aggregation of human and rabbit platelets [proceedings].
par: Westwick, J
Publié: (1976)